mevalonate promotes differentiation of regulatory t cells

Mevalonate is a precursor in a biosynthetic pathway that is important for the coordination of regulatory t cell (treg) proliferation and upregulation of the suppressive function that establishes the functional competency of tregs. the extensive role of mevalonate and its underlying effect on treg differentiation are still unclear. we found that mevalonate increases in vitro differentiation of induced tregs (itregs) without broadly affecting th1 and th17 cell differentiation. furthermore, an adoptive transfer study showed that mevalonate enhanced peripherally induced treg cells (ptregs) in mesenteric lymphocytes in vivo. mevalonate-treated itregs exhibited greater suppressive activity against effector cells than untreated tregs. mechanistically, mevalonate enhanced transforming growth factor (tgf)-β signaling by increasing the phosphorylation of smad3, but not smad2, and by promoting foxp3 expression. furthermore, we demonstrated that mevalonate treatment ameliorated dextran sulfate sodium (dss)-induced colitis and resulted in an increased percentage of tregs in vivo. our results suggest that mevalonate enhanced treg differentiation and ameliorated dss colitis, indicating its potential for treatment of inflammatory diseases.